Rafa Laboratories Ltd.

ILA 1,717As of Sun 8 Nov 2026, 12:00 UTC
TASE:RAFAHealthcare
Country Israel
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Medical (Pharmaceuticals)
Beta (5Y) —
PE TTM 398.0
TSR TTM —
Mkt cap ILS 1.682B
ROIC 53.08%
SE Grade™
Value
Quality
Moat
Consensus
Reference
ILA 2,186
27.29%
27.37%
Hold 5|11|9|9|12
4Q25
1Q26
2Q26
3Q26
Earnings per shareILS
25.34
27.56
29.69
31.66
22.65%
27.12%
27.92%
27.66%
RevenueILS M
115.2
114.7
121.3
123.1
13.39%
7.17%
8.53%
12.34%
Peers (US$527.8M)
Cap (US$)
PE
402.8M
19.69x
38.71M
—
564.1M
30.44x
Capital
TTM
5Y
10Y
Leveragex
2.705
0.750
0.581
EBIT/Intx
4.703
0.215
0.212
Own earn%
(47.79)
71.01
50.11
Sh yield%
22.53
34.53
36.40
Owners
Insiders/Inst%
14.32
78.06
Short interest%
3.34
SBC / revenue%
2.46
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
29–35
$1 testx
0.0
Incr. ROIC%
11